Sharon Richardson
InvestorDirector on the NBDF Board at Pathway to Cures
Find your path to Sharon
19 people in our graph share verified history with Sharon — schools, employers, funds. One of them is your warm intro.
Teri WilleyunlockedSharon: together at Pathway to Cures
×11Sharon: together at Pathway to Cures
About
Richardson is a pharmaceutical medical affairs leader with 28 years of experience, having held senior roles at Astellas, Spark Therapeutics, Baxter, and Eisai. She serves as a Director on the NBDF Board.
Colleagues at Pathway to Cures
Amy L. Dunn
Chair, Medical and Scientific Advisory Council (MASAC) for NBDF at Pathway to Cures
Beth Whitehouse
NBDF Senior Vice President for Advancement at Pathway to Cures
Brian Andrew
Investment Committee Chair at Pathway to Cures
Christine Brennan
Investment Committee Member at Pathway to Cures
Geeta Vemuri
Managing Partner, Founder at Agent Capital
Gilbert C. White
P2C Board Vice Chair & Secretary at Pathway to Cures
Gilbert C. White, II
P2C Board Vice Chair & Secretary at Pathway to Cures
Glenn Pierce
Scientific Advisory Group Co-Chair at Pathway to Cures
Frequently asked questions
- Who is Sharon Richardson?
- Richardson is a pharmaceutical medical affairs leader with 28 years of experience, having held senior roles at Astellas, Spark Therapeutics, Baxter, and Eisai. She serves as a Director on the NBDF Board.
- Where does Sharon Richardson work?
- Sharon Richardson is Director on the NBDF Board at Pathway to Cures.